This indicates that ASB3 inhibits CRC cell proliferation as a tumor suppressor and that dysfunctions of ASB3 resulting from mutations or down-regulation are among the possible events that lead to CRC pathogenesis or progression. This evidence concerns the gene ASB3 and neoplasm.